STK4 and liver cancer: These results suggested that STK4 knockdown upregulates IRAK1 expression and thus the activation of NF-κB activity revealed by the increase in the levels of proinflammatory cytokines, consequently impairing SS-b2-induced inhibition of liver cancer development.